47 results
8-K
EX-99.1
TSVT
2seventy bio Inc
5 Apr 24
Regulation FD Disclosure
9:22am
than the disease. Importantly, we remain focused on accomplishing these goals by
staying genuine and authentic to our “why” and keeping our people … , goals, plans and objectives and involve inherent risks, assumptions and uncertainties, including internal or external factors that could delay, divert
8-K
EX-99.1
TSVT
2seventy bio Inc
18 Mar 24
Departure of Directors or Certain Officers
7:04am
the disease. Importantly, we remain focused on accomplishing these goals by staying genuine and authentic to our “why” and keeping our people and culture … -looking statements. Such forward-looking statements are based on current expectations and projections about our future financial results, goals, plans
8-K
EX-99.1
TSVT
2seventy bio Inc
5 Mar 24
2seventy bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Progress
7:03am
focused on accomplishing these goals by staying genuine and authentic to our “why” and keeping our people and culture top of mind every day.
For more
8-K
EX-99.1
59x5ktqs1zysvn8pmhnc
5 Feb 24
Bristol Myers Squibb and 2seventy bio Share Update on U.S. FDA Oncologic Drugs Advisory Committee Meeting for Abecma in Triple-Class Exposed Multiple
7:02am
8-K
EX-99.1
kjx0 ho3zmiu0y
30 Jan 24
2seventy bio Announces New Strategic Path Forward
7:48am
8-K
EX-99.2
sx1x5gekos6eou3201c
12 Dec 23
Regulation FD Disclosure
7:25am
8-K
EX-99.1
fkguyee1 zu
20 Nov 23
Other Events
7:20am
8-K
EX-99.1
hdq862y3zag02kbe
14 Nov 23
2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress
12:00am
8-K
EX-99.1
2c2s4 y0i4
12 Sep 23
2seventy bio Announces Strategic Restructuring to Prioritize Growth of Abecma, Streamline Pipeline Advancement and Preserve Financial Runway
7:13am
8-K
EX-99.1
6zv v9ef8jrwzid4df
14 Aug 23
2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress
7:02am
8-K
EX-99.1
3jn8dmlrhr86kf
14 Jun 23
Unleash Time 2seventy bio company presentation June 2023
7:02am
8-K
EX-99.2
lkum8ij4xt
14 Jun 23
Unleash Time 2seventy bio company presentation June 2023
7:02am
8-K
EX-99.2
lmlt69o 7o
19 May 23
Regulation FD Disclosure
6:07am
8-K
EX-99.1
mbv5s5
17 May 23
2seventy bio Presents Broad Range of New Data Highlighting Novel Approaches Across its Cell Therapies Portfolio
7:31am
8-K
EX-99.1
gd989tkw3ob gyqt
3 May 23
2seventy bio Reports First Quarter Financial Results and Recent Operational Progress
4:11pm
8-K
EX-99.1
p0a6qijjyeznccj41r
1 May 23
Other Events
7:02am
PRE 14A
4bmtlfumard
18 Apr 23
Preliminary proxy
5:21pm